Development
Biodesix, Inc.
BDSX
$0.3029
$0.02117.49%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -9.14M | -10.95M | -13.36M | -18.70M | -20.34M |
| Total Depreciation and Amortization | 1.31M | 1.24M | 1.42M | 1.55M | 1.65M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.29M | 3.71M | 2.65M | 3.83M | 6.19M |
| Change in Net Operating Assets | -6.73M | 2.17M | 10.23M | 5.65M | 559.00K |
| Cash from Operations | -12.28M | -3.84M | 937.00K | -7.69M | -11.95M |
| Capital Expenditure | -2.98M | -5.84M | -6.42M | -7.68M | -1.93M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -17.00K | -41.00K | -55.00K | -30.00K | -57.00K |
| Cash from Investing | -3.00M | -5.88M | -6.47M | -7.71M | -1.99M |
| Total Debt Issued | 10.00M | -- | -- | -- | 30.00M |
| Total Debt Repaid | -13.00K | -12.00K | -12.00K | -12.00K | -23.57M |
| Issuance of Common Stock | 12.81M | 15.54M | 81.00K | 426.00K | 41.69M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.07M | -3.38M | -2.40M | -2.84M | -6.28M |
| Cash from Financing | 21.73M | 12.15M | -2.33M | -2.42M | 41.85M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.44M | 2.43M | -7.87M | -17.81M | 27.91M |